Treatment of mycosis fungoides with total skin electron beam: Response and relapse by ethnicity and sex

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 5, 2013, Pages 481-485

  Hinds, Ginette A ^a   Alhariri, Jihad ^a   Klein, Rhonda Q ^b   Wilson, Lynn D ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Cutaneous T cell lymphoma; Mycosis fungoides; Total skin electron beam; Women

Indexed keywords

BEXAROTENE; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETRETIN; INTERFERON; METHOTREXATE; METHOXSALEN; PSORALEN; STEROID;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONFERENCE PAPER; DISEASE DURATION; ETHNICITY; FEMALE; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOSIS FUNGOIDES; ORTHOVOLTAGE UNIT; RACE; RELAPSE; SEX DIFFERENCE; SYSTEMIC THERAPY; TOTAL SKIN ELECTRON THERAPY; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET IRRADIATION;

AGED; ELECTRONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

EID: 84885023034     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31825494d3     Document Type: Conference Paper

References (18)

1. Criscione VD, Weinstock M. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143:854-859. (Pubitemid 47076482)
2. Sun G, Berthelot C, Li Y, et al. Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides. J Am Acad Dermatol. 2009;60:231-235.
3. Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6:397-405.
4. Hinds GA, Heald P. Cutaneous T-cell lymphoma in skin of color. J Am Acad Dermatol. 2009;60:359-375.
5. Yones SS, Palmer RA, Garibaldinos TT, et al. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen UV-A therapy vs narrowband UV-B therapy. Arch Dermatol. 2006;142:836-842. (Pubitemid 44079782)
6. Wang F, Garza LA, Cho S, et al. Effect of increased skin pigmentation on the antifribrotic response of human skin to UVA1 phototherapy. Arch Dermatol. 2008;144:851-858. (Pubitemid 352039737)
7. Jones G, Wilson LD, Fox-Goguen L. Total skin electron beam radiotherapy for patients who have mycosis fungoides. Hematol Oncol Clin North Am. 2003;17:1421-1434. (Pubitemid 37523678)
8. Quiros PA, Jones GW, Kacinski BM, et al. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys. 1997;38:1027-1035. (Pubitemid 27353683)
9. Price NM, Hoppe RT, Constantine VS, et al. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy. Cancer. 1977;40:2851-2853.
10. Wilson LD, Jones GW, Kim D, et al. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol. 2000;43(pt 1):54-60. (Pubitemid 30439713)
11. Kashani-Sabet M, McMillan A, Zackheim HS. A modified staging classification for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2001;45:700-706. (Pubitemid 33032566)
12. Jones GW, Hoppe RT, Glatstein E. Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9:1057-1076.
13. Yu JB, Khan AM, Jones GW, et al. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study. Am J Clin Oncol. 2009;32:142-144.
14. Wilson LD, Kacinski BM, Jones GW. Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys. 1998;40:109-115. (Pubitemid 28027574)
15. Jones GW, Rosenthal D, Wilson LD. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome). Cancer. 1999;85: 1985-1995. (Pubitemid 29202774)
16. Jones GW, Tadros A, Hodson DI, et al. Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY. Int J Radiat Oncol Biol Phys. 1994;28: 839-845.
17. Ysebaert L, Truc G, Dalac S, et al. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation). Int J Radiat Oncol Biol Phys. 2004;58:1128-1134. (Pubitemid 38314795)
18. Duvic M, Apisarnthanarax N, Cohen DS, et al. Analysis of longterm outcomes of combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2003;49:35-49. (Pubitemid 36801629)